134 related articles for article (PubMed ID: 5267678)
1. Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines.
Granger GA; Moore GE; White JG; Matzinger P; Sundsmo JS; Shupe S; Kolb WP; Kramer J; Glade PR
J Immunol; 1970 Jun; 104(6):1476-85. PubMed ID: 5267678
[No Abstract] [Full Text] [Related]
2. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
Galli SJ; Adams RA
Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
[No Abstract] [Full Text] [Related]
3. [Immunoglobulin synthesis in the peripheral blood cells in children with acute leukemia and infectious mononucleosis].
Smirnov VV; Stefani DV; Balandina EK
Probl Gematol Pereliv Krovi; 1974 Jan; 19(1):54-7. PubMed ID: 4534128
[No Abstract] [Full Text] [Related]
4. [Immunoglobulin composition of the blood in hemolymphoblastosis].
Medina F; Tognella S
Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
[No Abstract] [Full Text] [Related]
5. HL-A antigens and hematologic malignancy.
Miller WV
Arch Intern Med; 1974 Mar; 133(3):397-9. PubMed ID: 4521322
[No Abstract] [Full Text] [Related]
6. The mechanism of action of soluble lymphocytic mediators. I. A pulse exposure test for the measurement of macrophage migration inhibitory factor.
Manheimer S; Pick E
Immunology; 1973 Jun; 24(6):1027-34. PubMed ID: 4736924
[TBL] [Abstract][Full Text] [Related]
7. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response.
Benezra D; Hochman A
Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061
[No Abstract] [Full Text] [Related]
8. Studies on macrophage migration inhibitory factor.
Yoshida T
Jpn J Med Sci Biol; 1971 Jun; 24(3):190. PubMed ID: 5315161
[No Abstract] [Full Text] [Related]
9. [Migration and phagocytosis functions of leukocytes in hemoblastosis].
Pietschmann H; Braun F; Sabeti M
Haematol Blood Transfus; 1978; 21():445-8. PubMed ID: 283043
[No Abstract] [Full Text] [Related]
10. [Quantification of granulocyte protection in hemoblastoses].
Senn HJ; Jungi WF
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):337-46. PubMed ID: 4139053
[No Abstract] [Full Text] [Related]
11. The effect of immunoregulatory alpha globulin (IRA) on antigen-mediated macrophage immobilization in vitro.
Davis RC; Cooperband SR; Mannick JA
J Immunol; 1971 Mar; 106(3):755-60. PubMed ID: 4100691
[No Abstract] [Full Text] [Related]
12. Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera.
Herberman RB; Nam JM
J Natl Cancer Inst; 1971 Aug; 47(2):489-94. PubMed ID: 5283788
[No Abstract] [Full Text] [Related]
13. Relation of the migration inhibitory factor (MIF) to delayed-type hypersensitivity reactions.
Bloom BR; Bennett B
Ann N Y Acad Sci; 1970 Feb; 169(1):258-65. PubMed ID: 5263842
[No Abstract] [Full Text] [Related]
14. [Lymphocyte blastogenesis in vitro in leukemias and lymphomas of childhood].
Fabris C; De Sanctis C; Ponzone A
Minerva Pediatr; 1971 Feb; 23(5):194-8. PubMed ID: 5280413
[No Abstract] [Full Text] [Related]
15. [Morphological appearances of several permanent lines (ICI) established from human leukemic blood: ultrastructural and chromosomal study of the cells before and after passage in continuous line].
Belpomme D; Le Borgne de Kaouël C; Paintrand M; Grandjon D; Venuat AM; de Nava C; Thoyer C; de Grouchy J; de Thé G; Mathé G
Rev Fr Etud Clin Biol; 1969 Nov; 14(9):848-60. PubMed ID: 5262768
[No Abstract] [Full Text] [Related]
16. Factors in delayed sensitivity: lymphocyte and macrophage cytotoxins in the tuberculin reaction.
Heise ER; Weiser RS
J Immunol; 1969 Sep; 103(3):570-6. PubMed ID: 5805437
[No Abstract] [Full Text] [Related]
17. The formation of immunoglobulins by circulating lymphocytes.
Van Furth R
Semin Hematol; 1969 Jan; 6(1):84-103. PubMed ID: 4180578
[No Abstract] [Full Text] [Related]
18. [Applicability of lymphocyte culture as a clinical function test].
Heine KM; Stobbe H
Dtsch Gesundheitsw; 1967 Oct; 22(42):1977-80. PubMed ID: 5600926
[No Abstract] [Full Text] [Related]
19. [Clinical significance of the lymphocyte transformation test].
Urasiñski I; Lisiewicz J
Pol Tyg Lek; 1971 Jul; 26(29):1124-7. PubMed ID: 4941500
[No Abstract] [Full Text] [Related]
20. Characterization of the factor in L-cell conditioned medium capable of stimulating colony formation by mouse marrow cells in culture.
Austin PE; McCulloch EA; Till JE
J Cell Physiol; 1971 Apr; 77(2):121-34. PubMed ID: 5572424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
